In addition, recent evidence showed that NT-proBNP also represents a useful prognostic biomarker in septic patients (31–33), non-cardiac surgery patients (34), patients without heart failure (35), and an unselected cohort of critically ill patients (36, 37). Here, NPPB is linked to heart failure.